Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumit Bhatnagar

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Chemistry & Biology|July 14, 2015
A 45-Amino-Acid Scaffold Mined from the PDB for High-Affinity Ligand EngineeringMax A Kruziki, Sumit Bhatnagar, Daniel R Woldring, et al.
Clinical and Translational Science|August 5, 2025
Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib DevelopmentSumit Bhatnagar, Sven Stodtmann, Yuli Qian, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2021
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approachSumit Bhatnagar, Dwaipayan Mukherjee, Ahmed Hamed Salem, et al.
Scientific Reports|March 13, 2019
Oral and Subcutaneous Administration of a Near-Infrared Fluorescent Molecular Imaging Agent Detects Inflammation in a Mouse Model of Rheumatoid ArthritisSumit Bhatnagar, Eshita Khera, Jianshan Liao, et al.
Molecular Pharmaceutics|April 27, 2018
Oral Administration and Detection of a Near-Infrared Molecular Imaging Agent in an Orthotopic Mouse Model for Breast Cancer ScreeningSumit Bhatnagar, Kirti Dhingra Verma, Yongjun Hu, et al.
Clinical Pharmacology and Therapeutics|July 10, 2024
Pharmacokinetics and Exposure-Response Analyses to Support Dose Selection of Upadacitinib in Crohn's DiseaseSumit Bhatnagar, Louisa Schlachter, Doerthe Eckert, et al.
Clinical and Translational Science|February 12, 2024
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritisSumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, et al.
Advances in Therapy|April 1, 2026
Efficacy and Safety of Ravagalimab in Patients with Moderate-to-Severe Ulcerative Colitis: Data from a Phase 2a TrialLaurent Peyrin-Biroulet, John Paul Seenan, Alessandro Armuzzi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled TrialJoan T Merrill, Yoshiya Tanaka, David D'Cruz, et al.
Clinical Pharmacology and Therapeutics|July 21, 2020
Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development ParadigmVijayalakshmi Chelliah, Georgia Lazarou, Sumit Bhatnagar, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Chemistry & Biology|July 14, 2015
A 45-Amino-Acid Scaffold Mined from the PDB for High-Affinity Ligand EngineeringMax A Kruziki, Sumit Bhatnagar, Daniel R Woldring, et al.
Clinical and Translational Science|August 5, 2025
Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib DevelopmentSumit Bhatnagar, Sven Stodtmann, Yuli Qian, et al.
Cancer Chemotherapy and Pharmacology|January 5, 2021
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approachSumit Bhatnagar, Dwaipayan Mukherjee, Ahmed Hamed Salem, et al.
Scientific Reports|March 13, 2019
Oral and Subcutaneous Administration of a Near-Infrared Fluorescent Molecular Imaging Agent Detects Inflammation in a Mouse Model of Rheumatoid ArthritisSumit Bhatnagar, Eshita Khera, Jianshan Liao, et al.
Molecular Pharmaceutics|April 27, 2018
Oral Administration and Detection of a Near-Infrared Molecular Imaging Agent in an Orthotopic Mouse Model for Breast Cancer ScreeningSumit Bhatnagar, Kirti Dhingra Verma, Yongjun Hu, et al.
Clinical Pharmacology and Therapeutics|July 10, 2024
Pharmacokinetics and Exposure-Response Analyses to Support Dose Selection of Upadacitinib in Crohn's DiseaseSumit Bhatnagar, Louisa Schlachter, Doerthe Eckert, et al.
Clinical and Translational Science|February 12, 2024
Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritisSumit Bhatnagar, Doerthe Eckert, Sven Stodtmann, et al.
Advances in Therapy|April 1, 2026
Efficacy and Safety of Ravagalimab in Patients with Moderate-to-Severe Ulcerative Colitis: Data from a Phase 2a TrialLaurent Peyrin-Biroulet, John Paul Seenan, Alessandro Armuzzi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled TrialJoan T Merrill, Yoshiya Tanaka, David D'Cruz, et al.
Clinical Pharmacology and Therapeutics|July 21, 2020
Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development ParadigmVijayalakshmi Chelliah, Georgia Lazarou, Sumit Bhatnagar, et al.
Pageof 2